Samir H. Moussa, Ph.D.
Affiliations: | 2007-2012 | Microbiology | Texas A & M University, College Station, TX, United States |
| 2012-2015 | MBIB | Harvard Medical School, Boston, MA, United States |
Area:
Molecular Biology, Biochemistry, Microbiology BiologyGoogle:
"Samir Moussa"Parents
Sign in to add mentor| Ryland F. Young | grad student | 2012 | Texas A & M | |
| (Deciphering lysis and its regulation in bacteriophage T4.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Krieger I, Kuznetsov V, Chang JY, et al. (2020) The Structural Basis of T4 Phage Lysis Control: DNA as the Signal for Lysis Inhibition. Journal of Molecular Biology |
| Miller AA, Shapiro AB, McLeod S, et al. (2020) In vitro Characterization of ETX1317, a broad-spectrum β-lactamase inhibitor that restores and enhances β-lactam activity against multidrug resistant Enterobacteriales, including carbapenem-resistant strains. Acs Infectious Diseases |
| McLeod SM, Moussa SH, Hackel MA, et al. (2020) activity of sulbactam-durlobactam against complex isolates collected globally from 2016-2017. Antimicrobial Agents and Chemotherapy |
| Barnes MD, Kumar V, Bethel CR, et al. (2019) Targeting Multidrug-Resistant spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent. Mbio. 10 |
| Iyer R, Moussa SH, Tommasi R, et al. (2018) Titrating levels of TolC in E. coli: a sensitive approach to quantify efflux. Acs Infectious Diseases |
| Iyer R, Moussa SH, Durand-Réville TF, et al. (2017) Acinetobacter baumannii OmpA Is a Selective Antibiotic Permeant Porin. Acs Infectious Diseases |
| McLeod SM, Shapiro AB, Moussa SH, et al. (2017) The frequency and mechanism of spontaneous resistance to sulbactam combined with the novel β-lactamase inhibitor ETX2514 in clinical isolates of Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy |
| Durand-Réville TF, Guler S, Comita-Prevoir J, et al. (2017) ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii. Nature Microbiology. 2: 17104 |
| McLeod S, Shapiro A, Moussa S, et al. (2016) Sulbactam Combined With the Novel β-lactamase Inhibitor ETX2514 for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infections Open Forum Infectious Diseases. 3 |
| Santiago M, Matano LM, Moussa SH, et al. (2015) A new platform for ultra-high density Staphylococcus aureus transposon libraries. Bmc Genomics. 16: 252 |